Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "economics"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"140 - Specific philosophical schools"
Showing
21
-
25
of
25
Search:
'"economics"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
21
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal, Humanized /
economics
...
”
Read Now
22
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal, Humanized /
economics
...
”
Read Now
23
Pharmacoeconomic report: Satralizumab (Enspryng) : (Hoffmann-La Roche Limited) : indication : neuromyelitis optica spectrum disorder
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...CADTH undertook reanalyses of the sponsor's
economic
models for satralizumab administered...
”
Read Now
24
Pharmacoeconomic review report: Tildrakizumab (Ilumya) : (Sun Pharma Global FZE) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasis who are...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
... the clinical effectiveness of tildrakizumab; additionally, the
economic
model did not allow CADTH to assess...
”
Read Now
25
Pharmacoeconomic report: Eculizumab (Soliris) : Alexion Pharma Canada Corporation : indication : adult patients with generalized myasthenia gravis
Published 2020
Canadian Agency for Drugs and Technologies in Health
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 140 - Specific philosophical schools
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
330 - Economics
23
610 - Medicine & health
10
700 - The arts; fine & decorative arts
6
Language
English
25
Collection
National Center for Biotechnology Information
25
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
6
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
4
Campbell, Kaitryn
2
Grobelna, Aleksandra
2
Wells, Charlotte
2
more ...
Young, Calvin
2
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=2&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22140+-+Specific+philosophical+schools%22&lookfor=%22economics%22&type=AllFields
Send by Email
×
Loading...